US › Healthcare

Painreform Ltd (PRFX)

US · Healthcare · Drug Manufacturers - Specialty & Generic

$1.13+13.00%

Last close · 2026-08-04

Latest quarter · ended 2025-12-31

Revenue

$8,500

Net profit

$-1.3M

Profit YoY

+82.8%

EPS

$0.00

EPS estimate

$0.00

Net margin

-14,835.3%

Key statistics

Market cap

$3.0M

Forward P/E

0.0

P/B

0.36

Book value

$10.29

EPS (TTM)

$-7.54

52-week high

$11.85

52-week low

$0.97

50-day MA

$1.46

200-day MA

$3.10

Beta

1.05

Analyst view

Analysts rate Painreform Ltd a hold (0 buy, 1 hold, 0 sell out of 1) with an average price target of $12.00.

Shareholding

Institutions

0.52%

Largest institutional holders

Fund	Stake
Citadel Advisors Llc	1.52%
Morgan Stanley - Brokerage Accounts	0.19%
UBS Group AG	0.10%
Advisor Group Holdings, Inc.	0.00%
SBI Securities Co Ltd	0.00%
XTX Topco Ltd	0.00%
TWO SIGMA SECURITIES, LLC	0.00%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Painreform Ltd — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.